بريمونيدين تيڤع
Country: Israel
Language: Arabic
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
BRIMONIDINE TARTRATE 0.15 %W/V
Available from:
TEVA PHARMACEUTICAL INDUST.LTD
ATC code:
S01EA05
Pharmaceutical form:
OPHTHALMIC SOLUTION
Administration route:
OCULAR
Manufactured by:
TEVA PHARMACEUTICAL INDUSTRIES LTD
Therapeutic group:
BRIMONIDINE
Therapeutic indications:
For the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Authorization date:
2009-12-01
